BIOXYNE LIMITED

BXN

equity

AUD $0.025

-0.0005 (-1.961%)

Updated: 19 Jan, 10:59 pm UTC

Description

BIOXYNE LIMITED is an ASX-listed biotechnology company that operates in Australia and worldwide. The main focus of the company is to develop and commercialise products for the healthcare, medical and industrial sectors. BIOXYNE is committed to creating products that make a difference to people's lives, with its objectives including the development of novel therapies and technologies, and the advancement of its existing products. The company is currently working on a number of projects, including the development of a novel molecular diagnostic platform, and a range of products to support medical professionals.

Activity
Last price		$0.025
Change		-0.0005 (-1.961%)
Bid/Ask		$0.025 - $0.026
Volume		239.00
Volume traded/total %		-359,050.00%
Volume avg (4w)		210,388.00
Open		$0.025
Day range		$0.025 - $0.025
Previous Close		$0.026
Last Trade		19 Jan, 10:59 pm UTC

Size
Market Cap		$16.97M
Market Rank		2024
Industry Rank		8

Fundamentals
Shares Issued		665.65M
Earnings Per Share (EPS)		$-0.0004
Dividends Per Share (DPS)		-
P/E Ratio		-

Similar to